Softwr

Healthcare · head to head

Oracle Clinical One vs Rad AI

Oracle Clinical One logo

Oracle Clinical One

Healthcare

Unified clinical trial data collection and randomisation on one Oracle Life Sciences platform

From
On request
Rated
-
Rad AI logo

Rad AI

Healthcare

Generative reporting and follow-up tracking for radiology, positioned outside the diagnostic device boundary

From
On request
Rated
-

The short version

  • Each has a real cost: Oracle Clinical One nothing about the commercial terms is published, so cost, implementation length and validation scope all emerge inside an enterprise sales process, and comparison shopping requires running parallel procurements.; Rad AI the products are not FDA cleared devices and are not intended to be, so any claim that Rad AI improves diagnostic accuracy is unsupported; what has been measured is reporting speed and follow-up completion, not detection.
  • They diverge on capability: Oracle Clinical One covers Unified platform, Rad AI covers Impressions.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Oracle Clinical One and Rad AI actually diverge.

Attributes where Oracle Clinical One and Rad AI differ
AttributeOracle Clinical OneRad AI
PlatformsWeb, iOS, AndroidWindows, Web, Cloud

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Oracle Clinical One

  • Unified platform
  • Data collection
  • Randomisation and supplies
  • No-code study build
  • Regulatory compliance
  • Mid-study changes
  • Integrations
  • Cloud delivery

Only in Rad AI

  • Impressions
  • Reporting
  • Continuity
  • Style learning
  • Omni Reconcile
  • PACS and dictation embedding
  • Patient outreach workflows
  • Audit reporting

What people use each for

The jobs each tool is most often brought in to do.

Oracle Clinical One

  • A sponsor running a complex Phase III where randomisation errors between separate EDC and RTSM vendors have already cost timenot Rad AI
  • A pharmaceutical company already on Oracle Clinical or InForm that needs a supported migration path off end-of-life systemsnot Rad AI
  • A trial with adaptive randomisation and drug supply forecasting that would otherwise need custom programming per amendmentnot Rad AI
  • A CRO standardising study build across many sponsor programmes on one validated platformnot Rad AI

Rad AI

  • A private radiology practice whose read volume has grown faster than it can recruit and that wants dictation time per study reduced without changing PACSnot Oracle Clinical One
  • A health system losing revenue and exposing itself to liability because recommended follow-up imaging on incidental findings is never bookednot Oracle Clinical One
  • A radiology department standardising impression quality across a mixed group of employed and locum radiologistsnot Oracle Clinical One
  • A group deploying an AI tool that must not trigger a device validation programme, because governance capacity is already consumed by a triage algorithm rolloutnot Oracle Clinical One

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Oracle Clinical One

  • Nothing about the commercial terms is published, so cost, implementation length and validation scope all emerge inside an enterprise sales process, and comparison shopping requires running parallel procurements.
  • Placing data collection and randomisation with a single vendor concentrates risk: an outage or a defect affects both of the systems your sites cannot work without.
  • Mid-study amendments are routine in trials but flow through the vendor change control process, and change orders are where the real cost of an Oracle trial platform accumulates after signature.
  • Implementation and study build require specialist staff or Oracle services, so the practical time from contract to first patient in is measured in months, not weeks.
  • It is aimed squarely at sponsors and CROs with established trial operations, and a small biotech running its first study will find the platform, the contracting and the validation burden heavier than its team can absorb.

Rad AI

  • The products are not FDA cleared devices and are not intended to be, so any claim that Rad AI improves diagnostic accuracy is unsupported; what has been measured is reporting speed and follow-up completion, not detection.
  • Generated impressions require radiologist review and signature, so the time saving evaporates in any group whose radiologists rewrite the draft rather than edit it, and adoption varies sharply by individual.
  • It is bound to your dictation platform, so a group planning to move off PowerScribe should sequence that decision first or expect to redo the Rad AI integration.
  • Continuity depends on the quality of recommendation language in historical reports, and departments with inconsistent phrasing get poor recall until reporting practice is standardised.
  • Pricing is not published and is structured per radiologist or per study depending on the product mix, which makes it hard to compare against image-analysis AI vendors that price per scan.

Pricing, plan by plan

Oracle Clinical One

On request
  • Clinical One Data Collection$undefined/year
    • Pricing only through Oracle sales
    • Priced against study count, sites and subjects
    • Study build and configuration services quoted separately
  • Clinical One Randomization and Supplies Management$undefined/year
    • Quoted alongside or independently of Data Collection
    • Randomisation strategy configuration included in the service
    • Supply forecasting and kit management

Rad AI

On request
  • Rad AI platform$undefined/year
    • Priced per radiologist or per study volume depending on product and contract
    • Impressions, Reporting and Continuity licensed separately
    • Annual subscription with implementation and integration scoped per site

Which should you pick?

Choose Oracle Clinical One if

  • You need unified platform.
  • You work on Web, iOS, Android.
  • You also want data collection.

Choose Rad AI if

  • You need impressions.
  • You work on Windows, Web, Cloud.
  • You also want reporting.

Questions people ask

Is Oracle Clinical One or Rad AI better?
Neither clearly leads. Oracle Clinical One starts at On request and Rad AI at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Oracle Clinical One or Rad AI?
Oracle Clinical One starts at On request and Rad AI at On request.
Does Oracle Clinical One or Rad AI run on more platforms?
Oracle Clinical One runs on Web, iOS, Android. Rad AI runs on Windows, Web, Cloud.
What is Oracle Clinical One best used for?
Oracle Clinical One is most often used for a sponsor running a complex phase iii where randomisation errors between separate edc and rtsm vendors have already cost time, a pharmaceutical company already on oracle clinical or inform that needs a supported migration path off end-of-life systems, a trial with adaptive randomisation and drug supply forecasting that would otherwise need custom programming per amendment, a cro standardising study build across many sponsor programmes on one validated platform. Of those, a sponsor running a complex phase iii where randomisation errors between separate edc and rtsm vendors have already cost time and a pharmaceutical company already on oracle clinical or inform that needs a supported migration path off end-of-life systems are not what Rad AI is typically brought in for.
What can Oracle Clinical One do that Rad AI cannot?
Oracle Clinical One covers Unified platform, Data collection, Randomisation and supplies, No-code study build. Rad AI covers Impressions, Reporting, Continuity, Style learning.

Answered from the vendors’ own pages

Oracle Clinical One: What replaced Oracle Clinical and InForm?

Clinical One is the current Oracle Life Sciences platform, and sponsors on the older Oracle Clinical and InForm products are the primary migration audience.

Rad AI: Is Rad AI FDA cleared?

No, and by design. The products draft text and manage follow-up workflow rather than interpreting images, so they fall outside the device pathway. Treat any diagnostic accuracy claim with scepticism.

Oracle Clinical One: Can I buy randomisation without data collection?

Yes. Clinical One Randomization and Supplies Management can integrate with a third-party EDC if you want to keep an incumbent capture system.

Rad AI: Does the radiologist still sign the report?

Yes. Output is a draft that the radiologist reviews and signs; nothing is released autonomously.

Oracle Clinical One: Is pricing published?

No. Every element, including licence, study build, implementation and validation, comes through Oracle sales.

Rad AI: Which product actually pays for itself?

Continuity has the clearest financial case, because recommended follow-up imaging that gets completed is billable work that currently does not happen.

Oracle Clinical One: Is it validated for regulated trials?

It is delivered as a validated cloud service with GxP documentation and Part 11 aligned audit trails, but sponsor-level validation of your own configuration remains your responsibility.

Rad AI: Will it work with our dictation system?

It is deepest with Nuance PowerScribe. Confirm your specific dictation and PACS combination before contracting, because integration depth is the main deployment variable.

Share

Related pages

Other head to heads